BIOHAVEN PHARMACTL HLDG CO L's ticker is BHVN and the CUSIP is G11196105. A total of 186 filers reported holding BIOHAVEN PHARMACTL HLDG CO L in Q3 2019. The put-call ratio across all filers is 0.14 and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $9,291,000 | -51.8% | 130,900 | -6.4% | 2.10% | -51.2% |
| Q4 2021 | $19,282,000 | -21.3% | 139,900 | -20.7% | 4.30% | -27.3% |
| Q3 2021 | $24,490,000 | +43.1% | 176,400 | 0.0% | 5.91% | +30.7% |
| Q2 2021 | $17,113,000 | +41.9% | 176,400 | 0.0% | 4.52% | +41.7% |
| Q1 2021 | $12,057,000 | -29.8% | 176,400 | -12.0% | 3.19% | -32.0% |
| Q4 2020 | $17,178,000 | +92.3% | 200,400 | +45.9% | 4.69% | +62.7% |
| Q3 2020 | $8,931,000 | +186.3% | 137,400 | +205.3% | 2.88% | +178.0% |
| Q2 2020 | $3,119,000 | +39.8% | 45,000 | -11.7% | 1.04% | +25.4% |
| Q2 2019 | $2,231,000 | +44.5% | 50,949 | +69.8% | 0.83% | +45.1% |
| Q1 2019 | $1,544,000 | – | 30,000 | – | 0.57% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knoll Capital Management, LLC | 900,844 | $136,181,000 | 79.57% |
| RP Management, LLC | 1,111,111 | $167,967,000 | 77.60% |
| JET CAPITAL INVESTORS L P | 1,707,500 | $258,942,000 | 53.95% |
| Alpine Global Management, LLC | 373,999 | $56,537,000 | 13.23% |
| Chicago Capital Management, LLC | 154,585 | $23,443,000 | 12.75% |
| FIFTH LANE CAPITAL, LP | 140,000 | $21,164,000 | 11.03% |
| OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) | 3,784,482 | $572,100,000,000 | 10.85% |
| Eversept Partners, LP | 637,139 | $96,316,303 | 8.35% |
| EQUITEC PROPRIETARY MARKETS, LLC | 187,100 | $28,284,000 | 7.45% |
| HARVEST MANAGEMENT LLC | 48,503 | $7,332,000 | 5.92% |